Quantcast
Scientists Take Step Towards Drug To Treat Norovirus Stomach

Scientists Take Step Towards Drug To Treat Norovirus Stomach Bug

Provided by the University of Cambridge An experimental drug currently being trialed for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of...

Latest Antiviral drug Stories

2014-10-01 12:30:59

Data from 25 accepted abstracts include results from: NORTH CHICAGO, Ill., Oct. 1, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that data from its ongoing Phase 1 through Phase 3 hepatitis C clinical development programs will be presented at The Liver Meeting®, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, November 7-11, 2014. Abstracts will be presented highlighting results from AbbVie's investigational treatment combining three...

2014-09-29 08:30:22

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Infectious Disease Treatment Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to...

2014-09-18 08:29:39

MILFORD, Mass., Sept. 18, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RNA viruses, today announced a research collaboration with the National Institutes of Health (NIH) for animal testing of the Company's lead compound, SB 9200, against multiple viral pathogens, classified as "Special Pathogens," against which currently there are no effective antiviral therapies. SB 9200, derived...

2014-09-15 23:03:41

Complimentary Hayes, Inc. webinar reviews new management options and their effects on patient outcomes. Lansdale, PA (PRWEB) September 15, 2014 For the 3.2 million people in the United States infected with the hepatitis C virus, disease management can be costly and debilitating. But are the new agents recently approved by the Food and Drug Administration (FDA) a better way to manage the disease? Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—What You Need to Know is a...

2014-08-18 04:21:18

CYPRESS, Calif. and LONDON, Aug. 18, 2014 /PRNewswire-iReach/ -- Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (Flunisyn(TM)) designed to protect humans from all strains of seasonal and pandemic influenza A. To determine the effectiveness of Flunisyn(TM) ITS produced its own live influenza challenge agent derived from the recently circulating Influenza A/California/2009 (H1N1)...

2014-07-29 08:32:01

Frost & Sullivan: The market is looking for a reasonably priced and convenient alternative to Gilead's blockbuster Sovaldi MOUNTAIN VIEW, Calif., July 29, 2014 /PRNewswire/ -- Drug development for hepatitis C virus (HCV) antivirals has amplified with rising incidence rates and the intense need for curative therapy in the absence of a preventative vaccine. Change is underway as the market moves away from protease inhibitors and interferon regimens towards highly effective, easily-tolerated,...

University Of Arizona Scientists' Fishing Expedition Reveals Viral Diversity In The Sea
2014-07-21 03:46:48

University of Arizona A fishing expedition of microscopic proportions led by University of Arizona ecologists revealed that the lines between virus types in nature are less blurred than previously thought. Using lab-cultured bacteria as "bait," a team of scientists led by Matthew Sullivan has sequenced complete and partial genomes of about 10 million viruses from an ocean water sample in a single experiment. The study, published online on July 14 by the journal Nature, revealed that...

2014-07-15 12:28:37

Unprecedented Growth Will be Fuelled by Rapid Uptake of All-Oral, Interferon-Free Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., July 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the hepatitis C virus (HCV) population is large with more than 2 million diagnosed, chronically infected cases throughout the G7 markets (United States, France, Germany, Italy, Spain, United Kingdom and Japan). Many of these patients, including more than 270,000 with...

2014-07-03 10:47:18

University of Pennsylvania School of Medicine Less than 10 percent of people infected with hepatitis C are cured A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new,...

2014-06-11 16:27:28

ResolveHerpes is Designed to Boost the Body's Immune System and Allow it to Clear Out the Herpes Viruses HSV-1 and HSV-2 LOS ANGELES, June 11, 2014 /PRNewswire-iReach/ -- Resolve Herpes, a company that offers all-natural mineral formulations, has just announced the launch of a new and effective herpes treatment. Called ResolveHerpes, the product is designed to help boost the body's immune system, which in turn can help it naturally clear out the herpes viruses HSV-1 and HSV-2. Photo...


Latest Antiviral drug Reference Libraries

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

0_d42a67c9e67a58fec0ffaab2b08808b2
2011-01-11 14:10:55

Human rhinoviruses are the most common viral ineffective agents in humans and are the cause of the common cold. The infection proliferates between 33-35 °C causing most reproduction to occur in the nose. It is a species in the genus Enterovirus of the Picornaviridae family of viruses. There are 99 recognized types of Human Rhinoviruses that are differentiated by their surface proteins. They are amongst the smallest viruses and lytic in nature. They travel via aerosols of respiratory...

More Articles (2 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related